Adenocarcinoma Of Esophagus Active Not Recruiting Phase 2 Trials for Spartalizumab (DB14892)

Also known as: Adenocarcinoma of Oesophagus / Oesophageal Adenocarcinoma / Adenocarcinoma, Esophageal / Esophageal Adenocarcinomas / Esophageal Adenocarcinoma / Oesophageal adenocarcinoma NOS

IndicationStatusPhase
DBCOND0067383 (Adenocarcinoma Of Esophagus)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03365791PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic MalignanciesTreatment